EYET Insider Trading Activity and SEC Form 4 Filings
EYET insider trading summary
No open-market insider purchases or sales of Eyetech Pharmaceuticals Inc (EYET) have been reported on SEC Form 4 in the past 12 months.
Latest EYET insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 4, 2005 | Glenn Sblendorio | Chief Financial Officer | Sell | $224K (12,500 @ $17.90) |
| Nov 4, 2005 | Paul G Chaney | Chief Operating Officer | Sell | $277K (15,476 @ $17.89) |
| Nov 4, 2005 | Paul G Chaney | Chief Operating Officer | Sell | $1.4M (79,082 @ $17.89) |
| Nov 3, 2005 | Anthony P Adamis | Chief Scientific Officer | Sell | $1.9M (106,094 @ $17.68) |
| Nov 3, 2005 | Glenn Sblendorio | Chief Financial Officer | Sell | $926K (52,500 @ $17.63) |
| Aug 1, 2005 | David R Guyer | Chief Executive Officer | Sell | $177K (15,600 @ $11.33) |
| Aug 1, 2005 | Anthony P Adamis | Chief Scientific Officer | Sell | $60K (5,325 @ $11.35) |
| Aug 1, 2005 | Paul G Chaney | Chief Operating Officer | Sell | $32K (2,800 @ $11.33) |
| Aug 1, 2005 | Glenn Sblendorio | Chief Financial Officer | Sell | $21K (1,850 @ $11.35) |
| Jul 1, 2005 | Paul G Chaney | Chief Operating Officer | Sell | $36K (2,800 @ $12.68) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.